Výsledky vyhledávání - "A M E Schauwvlieghe"

Akademický článek

Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study.

Autor: A M E Schauwvlieghe, G Dijkman, J M Hooymans, F D Verbraak, C B Hoyng, M G W Dijkgraaf, T Peto, J R Vingerling, R O Schlingemann

Publikováno v: PLoS ONE, Vol 11, Iss 5, p e0153052 (2016)

To compare the effectiveness of bevacizumab and ranibizumab in the treatment of exudative age-related macular degeneration (AMD).Multicentre, randomized, controlled, double-masked clinical trial in 327 patients. The non-inferiority margin was 4 lette

Externí odkaz: https://doaj.org/article/e45a2c63efb948f29e52edb3987b2873

Zobrazit plný text záznamu

BILATERAL SEROUS RETINAL DETACHMENT AND UVEITIS ASSOCIATED WITH PEMBROLIZUMAB TREATMENT IN METASTATIC MELANOMA

Autor: Ewout W. de Vries, John B. A. G. Haanen, Joeri de Hoog, Ann-Sofie M E Schauwvlieghe

Publikováno v: Retinal cases & brief reports, 16(4), 430-434. Lippincott Williams and Wilkins
de Vries, E W, Schauwvlieghe, A-S, Haanen, J B & de Hoog, J 2022, ' BILATERAL SEROUS RETINAL DETACHMENT AND UVEITIS ASSOCIATED WITH PEMBROLIZUMAB TREATMENT IN METASTATIC MELANOMA ', Retinal cases & brief reports, vol. 16, no. 4, pp. 430-434 . https://doi.org/10.1097/ICB.0000000000000999

PURPOSE: To describe the pathological features, treatment, and resolution of pembrolizumab-associated retinal detachment. METHODS: A case report with a brief review of the literature and details of patient presentation, physical examination, systemic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21826e1b31630f1778e7cf618b898196
https://research.vumc.nl/en/publications/820c8c1b-796c-4c6d-947c-c55d86d459ce

Zobrazit plný text záznamu

Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion

Autor: Janneke J.C. van Lith-Verhoeven, Frank D. Verbraak, Carel B. Hoyng, Marcel G. W. Dijkgraaf, Maartje J.C. Vader, Ann-Sofie M E Schauwvlieghe, Reinier O. Schlingemann, Tunde Peto, Johannes R. Vingerling, Aeilko H. Zwinderman, Redmer van Leeuwen, Greetje Dijkman, Johanna M. M. Hooymans, Leonoor I. Los, Yvonne de Jong-Hesse

Publikováno v: Ophthalmology Retina. 4:576-587

Purpose: Comparing the efficacy of intravitreal injections of bevacizumab to ranibizumab in the treatment of macular edema (ME) resulting from retinal vein occlusion (RVO). Design: Comparative, randomized, double-masked, multicenter, noninferiority c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::79c87bb2d29a3325de087ac0c5921b09
https://doi.org/10.1016/j.oret.2019.12.019

Zobrazit plný text záznamu

Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME): The BRDME Study, a Randomized Trial

Autor: Maartje J C, Vader, Ann-Sofie M E, Schauwvlieghe, Frank D, Verbraak, Greetje, Dijkman, Johanna M M, Hooymans, Leonoor I, Los, Aeilko H, Zwinderman, Tunde, Peto, Carel B, Hoyng, Redmer, van Leeuwen, Johannes R, Vingerling, Annette C, Moll, Janneke J C, van Lith-Verhoeven, Marcel G W, Dijkgraaf, Reinier O, Schlingemann

Publikováno v: Ophthalmology. Retina. 4(8)

To generate conclusive evidence regarding the noninferiority of intravitreal bevacizumab compared with ranibizumab in patients with diabetic macular edema (DME).Comparative, randomized, double-masked, multicenter, noninferiority clinical trial.Eligib

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::229406449553eb4432168116fbe8f30b
https://pubmed.ncbi.nlm.nih.gov/32362552

Zobrazit plný text záznamu

Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Retinal Vein Occlusion: The Bevacizumab to Ranibizumab in Retinal Vein Occlusions (BRVO) study, a Randomized Trial

Autor: Maartje J C, Vader, Ann-Sofie M E, Schauwvlieghe, Frank D, Verbraak, Greetje, Dijkman, Johanna M M, Hooymans, Leonoor I, Los, Aeilko H, Zwinderman, Tunde, Peto, Carel B, Hoyng, Redmer, van Leeuwen, Johannes R, Vingerling, Yvonne, de Jong-Hesse, Janneke J C, van Lith-Verhoeven, Marcel G W, Dijkgraaf, Reinier O, Schlingemann

Publikováno v: Ophthalmology. Retina. 4(6)

Comparing the efficacy of intravitreal injections of bevacizumab to ranibizumab in the treatment of macular edema (ME) resulting from retinal vein occlusion (RVO).Comparative, randomized, double-masked, multicenter, noninferiority clinical trial. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4e8c9e26039f31b064f9d0cc4466dcd7
https://pubmed.ncbi.nlm.nih.gov/32107188

Zobrazit plný text záznamu

Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study

Autor: Marcel G. W. Dijkgraaf, Tunde Peto, Greet Dijkman, F. D. Verbraak, Johanna M. M. Hooymans, Reinier O. Schlingemann, Carel B. Hoyng, Johannes R. Vingerling, Ann-Sofie M E Schauwvlieghe

Publikováno v: PLoS One, 11, 5
PLoS ONE, Vol 11, Iss 5, p e0153052 (2016)
PLoS ONE
PLoS One, 11(5). Public Library of Science
PLoS ONE, 11(5). Public Library of Science
PLoS One (print), 11(5):e0153052. Public Library of Science
PLoS ONE, 11(5):e0153052. PUBLIC LIBRARY SCIENCE
PLoS One, 11
PLoS ONE, 11(5)
Schauwvlieghe, A M E, Dijkman, G, Hooymans, J M, Verbraak, F D, Hoyng, C B, Dijkgraaf, M G W, Peto, T, Vingerling, J R & Schlingemann, R O 2016, ' Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study ' PloS one, vol. 11, no. 5, pp. e0153052 . DOI: 10.1371/journal.pone.0153052

Contains fulltext : 167677.PDF (Publisher’s version ) (Open Access) PURPOSE: To compare the effectiveness of bevacizumab and ranibizumab in the treatment of exudative age-related macular degeneration (AMD). DESIGN: Multicentre, randomized, controll

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57fd80a88e2d04744412ad223876b3aa
https://hdl.handle.net/2066/167677

Zobrazit plný text záznamu

Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema

Autor: Reinier O. Schlingemann, R. Van Leeuwen, Frank D. Verbraak, Johannes R. Vingerling, Greet Dijkman, Annette C. Moll, Johanna M. M. Hooymans, Marcel G. W. Dijkgraaf, Ann-Sofie M E Schauwvlieghe, Carel B. Hoyng

Publikováno v: BMC ophthalmology, 15(1). BioMed Central
BMC Ophtalmology, 15:71. BioMed Central
BMC ophthalmology, 15, 71. BioMed Central
BMC Ophthalmology, 15. BioMed Central
Bmc ophthalmology, 15:71. BMC
BMC Ophthalmology, 15. BioMed Central Ltd.
BMC Ophthalmology, 15, pp. 71
BMC Ophthalmology, 15
BMC Ophthalmology
BMC Ophthalmology, 15, 71
Schauwvlieghe, A M E, Dijkman, G, Hooymans, J M, Verbraak, F D, Hoyng, C B, Dijkgraaf, M G W, van Leeuwen, R, Vingerling, J R, Moll, A C & Schlingemann, R O 2015, ' Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study) ', BMC Ophtalmology, vol. 15, 71 . https://doi.org/10.1186/s12886-015-0043-x

Contains fulltext : 154839.pdf (Publisher’s version ) (Open Access) BACKGROUND: The effectiveness of ranibizumab in the treatment of diabetic macular edema has been proven with large clinical trials. For bevacizumab only two clinical trials have be

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::085c499088b844d2388afc2d8018d34c
https://doi.org/10.1186/s12886-015-0043-x

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání